Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: A spanish cooperative group for the treatment of digestive tumors study

1. Sastre, J.
2. Luisa Maestro, M.
3. Gómez-España, A.
4. Rivera, F.
5. Valladares, M.
6. Massuti, B.
7. Benavides, M.
8. Gallén, M.
9. Marcuello, E.
10. Abad, A.
11. Arrivi, A.
12. Fernández-Martos, C.
13. González, E.
14. Tabernero, J.M.
15. Vidaurreta, M.
16. Aranda, E.
17. Díaz-Rubio, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1634/THEONCOLOGIST.2012-0048 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus